Indication
Lemtrada is indicated for adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- LemtradaCanada · 12 MG / 1.2 ML · Solution · Sanofi-Aventis Canada INCSame brand
- Lemtrada 12 MG Concentrado Para Solucion Para PerfusionSpain · 10,0 mg · concentrado para solución para perfusión · Sanofi BelgiumSame brand
- LemtradaCroatiaSame brand
- LEMTRADA 12 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Sanofi Belgium